Mannkind Corp

NASDAQ: MNKD
$7.44
+$0.18 (+2.5%)
Closing Price on November 6, 2024

MNKD Articles

The March 31 short interest data have been compared with the previous report, and short interest decreased in most of the selected biotech stocks.
The health care sector in general has rallied since Trump took over the presidency, but now that his repeal of the ACA fell through, the health care rally is called into question.
March came in like a lamb, as far as the markets were concerned. Judging by the most shorted stocks traded on the Nasdaq, short sellers overall seemed fairly enthusiastic about that.
The February 28 short interest data have been compared with the previous report, and short interest decreased in most of the selected biotech stocks.
With the bull market now eight years old and markets still hitting new highs, how have the short sellers been reacting to this pricey market?
The February 15 short interest data have been compared with the previous report, and short interest increased in all the selected biotech stocks.
The nearly eight-year old bull market marches on, with markets recently hitting all-time highs. And how are short sellers reacting?
As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears have to say about this rally.
Judging by the most shorted stocks traded on the Nasdaq in late January, those short sellers who remained active continued to be cautious.
As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears have to say about this rally.
Overall, the moves in the most shorted stocks traded on the Nasdaq were mixed and mild again between the December 30 and January 13 settlement dates.
As we have approached Trump’s inauguration, the health care sector in general has rallied. Now it’s time to see what the bears have to say about this rally.
Judging by the most shorted stocks traded on the Nasdaq, short sellers remained active also continued to be cautious as the year wound to its conclusion and many investors and traders were out for...
The December 15 short interest data have been compared with the previous report, and short interest was down in most of the selected biotech stocks.
Judging by the most shorted stocks traded on the Nasdaq, sellers continued to take a wait and see approach. Overall, moves in those stocks were mixed and mild between the November 30 and December 15...